Table 4 Previously published associations between TP53 status and overall survival, by estrogen receptor (ER) status and TP53 classification method.

Rossner³⁸

859 (307)

0.80 (0.47, 1.33)^a

X

Shiao⁴¹

47 (9)

0.64 (0.07, 5.51)

X

Coates⁹

1113 (303)

1.12 (0.89, 1.39)

X

Rossner³⁸

859 (128)

1.04 (0.59, 1.85)^a

X

Yamashita³⁹

73 (16)

2.36 (1.20, 4.67)

↓↓

Andersson⁴²

370 (105)

1.33 (0.92, 1.93)

↓

Song⁴

440 (227)

3.10 (1.02, 9.44)

↓↓

Powell⁵

1037 (178)

1.9 (1.3, 2.8)

↓↓

Iwaya⁴⁰

31 (5)

p < 0.01

↓↓

Pharoah¹

2319 (539)

2.0 (1.7, 2.5)

↓↓

Blaszyk⁶

90 (32)

p = 0.0001

↓↓

Silwal-Pandit⁷

1420 (402)

2.03 (1.65, 2.48)^a

↓↓

Olivier⁴³

1107 (144)

2.40 (1.70, 3.38)^b

↓↓

Dobes²

204 (54)

5.38 (2.14, 13.52)

↓↓

Shiao⁴¹

45 (9)

5.62 (1.37, 23.00)^c

↓↓

Bergh⁴⁴

297 (65)

p = 0.02^a

↓↓

Meric-Bernstam³,

165 (47)

p = 0.0004

↓↓

Ungerleider⁴⁵

1979 (663)

p < 0.0001

↓↓

Coates⁹

880 (171)

1.29 (0.98, 1.70)

↓

Caleffi²¹

106 (17)

p = 0.37

X

Coutant¹⁰

134 (49)

2.43 (0.96, 6.15)

X

Feeley²⁰

359 (48)

1.96 (1.00, 3.84)

↓↓

Silwal-Pandit⁷

1037 (195)

1.86 (1.39, 2.49)^a

↓↓

Coutant¹⁰

191 (101)

2.30 (1.25, 423)^d

↓↓

Coates⁹

212 (125)

0.62 (0.40, 0.97)

↑↑

Silwal-Pandit⁷

306 (196)

1.15 (0.77, 1.72)^a

X

Coutant¹⁰

64 (41)

p = 0.27

X

Caleffi²¹

86 (26)

p = 0.87

X